The biotech bi-weekly: AI, genomics and antibody discovery

Here’s what the biotech industry has been buzzing about over the last 2 weeks: the launch of an advanced organ-on-a-chip (OOC) solution, a tissue-based comprehensive genomic profiling assay, automated target enrichment protocols for genomic workflows and the launch of an AI command center to streamline science workflows. Products Developing organ-on-a-chip solutions CN Bio (Cambridge, UK), a provider of benchtop OOC solutions that accelerate drug discovery and development, has announced the launch of PhysioMimix® Core. Combining the capabilities of CN Bio’s existing suite of instruments, PhysioMimix Core is the first OOC solution to deliver validated performance across single-organ, multi-organ and higher-throughput...